Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion type Assertion NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_head.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion description "[In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of ?-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion evidence source_evidence_literature NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion SIO_000772 24505400 NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion wasDerivedFrom befree-2016 NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.
- NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_assertion wasGeneratedBy ECO_0000203 NP1153099.RAdh9fCNDF7ZHlF-2noF4vi7CDN7J3Tokg1MSBbw3Dmbs130_provenance.